2002
DOI: 10.1007/bf02493361
|View full text |Cite
|
Sign up to set email alerts
|

Validation issues arising from the new FDA guidance for industry on bioanalytical method validation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(20 citation statements)
references
References 3 publications
0
20
0
Order By: Relevance
“…Full validation of the analytical methods described in this report was performed in line with US Food and Drug Administration guidelines for validation of bioanalytical methods [11], including tests for selectivity, calibration curve, lower limit of quantfication (LLOQ), accuracy, precision and stability.…”
Section: Methods Validationmentioning
confidence: 99%
“…Full validation of the analytical methods described in this report was performed in line with US Food and Drug Administration guidelines for validation of bioanalytical methods [11], including tests for selectivity, calibration curve, lower limit of quantfication (LLOQ), accuracy, precision and stability.…”
Section: Methods Validationmentioning
confidence: 99%
“…Therefore, a series of decreasing MEA concentrations were tested. The LOD was defined to correspond to the lowest concentration with S/N higher than 3 while LOQ was the lowest concentration with an S/N higher than 10 and an acceptable accuracy ranged between ±20% and the acceptable precision was <20% . The linearity within a range of MEA concentrations (0.5, 1, 5, 20, 50, and 80 μg/mL) was assessed using the correlation coefficient R 2 .…”
Section: Methodsmentioning
confidence: 99%
“…For all the concentration levels of letosteine, the result was within the requirements of the guidelines for bioanalytical methods [14].…”
Section: Precision and Accuracymentioning
confidence: 99%